The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> July 12, 2019

Interview with the President and CEO: OraSure Technologies, Inc. (NASDAQ:OSUR)

Tang, Stephen S.
Stephen S. Tang, Ph.D., is President and Chief Executive Officer of OraSure Technologies, Inc. Dr. Tang became President and CEO of OraSure on April 1, 2018. Prior to becoming President and CEO, he joined the OraSure board of directors in April of 2011 and was the company’s Chairman of the board from November 2017 to March 2018. Prior to joining OraSure, Dr. Tang served as President and Chief Executive Officer of the University City Science Center, an urban research park and business incubator owned by more than 30 leading universities, medical schools and health networks in the greater Philadelphia, Pennsylvania, area. Prior to that, Dr. Tang held senior management and business development positions with several firms, including Olympus America, Inc., Millennium Cell Inc. and A.T. Kearney Inc. Dr. Tang holds a B.S. degree in chemistry from The College of William and Mary, an M.S. degree and Ph.D. in chemical engineering from Lehigh University and an MBA from The Wharton School of Business at the University of Pennsylvania. Profile
Word count: 3,081

TWST: What is OraSure Technologies, and can you talk about what you believe to be the core offerings and how it may differ from standard of care?

Dr.

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
Interview with the Co-CEO and the CAO: Planet 13 Holdings Inc. (OTCMKTS:PLNH)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy